Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...

Neutralising antibodies can prevent severe courses Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with weakened immune system or existing ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Bio-Rad Laboratories, Inc has introduced Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 ...

Your IP is registered with the company mentioned above and provides access to Life Science Sweden.

AI-assisted AAV capsid engineering has transformative potential in terms of accelerating and optimizing the development of gene therapies.

Transposons, also known as jumping genes or mobile genetic elements as they can replicate and reinsert themselves in the ...

The FDA has accepted under Priority Review the NDA for lenacapavir for the prevention of HIV as pre-exposure prophylaxis.

To become infectious, HIV has to undergo a maturation process, which involves a rearrangement of the matrix proteins (red). In an immature virus particle, the matrix proteins form a lose lattice ...

A new combination of microscopy methods has revealed exquisite detail of the virus assembly process used by herpes simplex virus during replication.

The virus is composed of three layers—a capsid that contains the viral DNA, a protein layer called the tegument and an outer envelope that is studded with viral glycoproteins (proteins with a ...

A Chinese team of virologists has found that this virus carries the risk of animal-to-human transmission. According to the South China Morning Post (SCMP), the new virus called HKU5-CoV-2 was ...